In inflammation, activated neutrophils adhere to endothelial cells and
aggregate with one another. While beta(2)-integrin and L-selectin are
essential for aggregation, their ligands remain to be identified. We
have previously shown that L-selectin mediates a carbohydrate-dependen
t interaction in aggregation (Simon et al: J Immunol 149:2765, 1992; R
ochon et al: J Immunol 152:1385. 1994). We have suggested that the L-s
electin counter-structure is a mucinlike protein and proposed that agg
regation occurs through a two-step process involving L-selectin, beta(
2)-integrin, and their distinct counter-structures (Bennett et al: J L
euk Biol 58:510, 1995). A candidate ligand for L-selectin is P-selecti
n glycoprotein ligand-l (PSGL-1). a mucinlike protein on neutrophils t
hat binds P- and E-selectin. Using flow cytometry we show that the num
ber and size of neutrophil aggregates is reduced with Fab fragments of
PL1, an anti-PSGL-1 monoclonal antibody that blocks the interaction b
etween P-selectin and PSGL-1 (Moore et al: J Cell Biol 128:661, 1995).
In addition, monoclonal antibodies to L-selectin and PSGL-1 were used
simultaneously to modulate the availability of these adhesion molecul
es on individual cell populations. The inhibition of aggregation by th
ese antibodies is consistent with L-selectin and PSGL-1 being counter-
structures. We suggest that L-selectin and PSGL-1 support a collisiona
l cell-cell interaction that represents the first step in neutrophil a
ggregation. (C) 1996 by The American Society of Hematology.